Anti-trust litigation filed against Dr Reddy’s Laboratories and other generic pharma companies in US Read more
US FDA approves Bristol Myers Squibb’s CAR-T cell therapy Breyanzi for relapsed large B-cell lymphoma after one prior therapy Read more
Bristol Myers Squibb and bluebird bio get US FDA nod for Abecma (idecabtagene vicleucel) to treat relapsed or refractory multiple myeloma Read more
